HEADER TRANSFERASE/TRANSFERASE INHIBITOR 01-APR-14 4P90 TITLE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN PAK1 IN COMPLEX WITH TITLE 2 COMPOUND 15 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PAK 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ALPHA-PAK,P21-ACTIVATED KINASE 1,PAK-1,P65-PAK; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PAK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.D.FERGUSON REVDAT 3 27-SEP-23 4P90 1 SOURCE REMARK REVDAT 2 24-DEC-14 4P90 1 SEQADV REVDAT 1 10-SEP-14 4P90 0 JRNL AUTH W.MCCOULL,E.J.HENNESSY,K.BLADES,M.R.BOX,C.CHUAQUI, JRNL AUTH 2 J.E.DOWLING,C.D.DAVIES,A.D.FERGUSON,F.W.GOLDBERG,N.J.HOWE, JRNL AUTH 3 P.D.KEMMITT,G.M.LAMONT,K.MADDEN,C.MCWHIRTER,J.G.VARNES, JRNL AUTH 4 R.A.WARD,J.D.WILLIAMS,B.YANG JRNL TITL IDENTIFICATION AND OPTIMISATION OF 7-AZAINDOLE PAK1 JRNL TITL 2 INHIBITORS WITH IMPROVED POTENCY AND KINASE SELECTIVITY. JRNL REF MEDCHEMCOMM 2014 JRNL REFN ESSN 2040-2511 JRNL DOI 10.1039/C4MD00280F REMARK 2 REMARK 2 RESOLUTION. 2.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 22308 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.209 REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 1147 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.49 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.61 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.99 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2845 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2495 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2686 REMARK 3 BIN R VALUE (WORKING SET) : 0.2478 REMARK 3 BIN FREE R VALUE : 0.2795 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.59 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 159 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4187 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 43 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 71.55 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 87.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.76590 REMARK 3 B22 (A**2) : 2.15860 REMARK 3 B33 (A**2) : 5.60730 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -13.92900 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.462 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.439 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.240 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.477 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.248 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4321 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5838 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1550 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 115 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 595 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4321 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 568 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4882 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.15 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.93 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.66 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -1.0859 -23.2297 15.1449 REMARK 3 T TENSOR REMARK 3 T11: -0.2225 T22: -0.2068 REMARK 3 T33: -0.2220 T12: -0.0098 REMARK 3 T13: 0.0876 T23: 0.0782 REMARK 3 L TENSOR REMARK 3 L11: 3.4049 L22: 5.6285 REMARK 3 L33: 8.0361 L12: 0.4125 REMARK 3 L13: -3.0491 L23: -3.2101 REMARK 3 S TENSOR REMARK 3 S11: -0.1808 S12: -0.1419 S13: -0.5833 REMARK 3 S21: 0.5279 S22: 0.2825 S23: 0.6764 REMARK 3 S31: -0.4782 S32: -0.6010 S33: -0.1017 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 31.8411 23.1968 14.7822 REMARK 3 T TENSOR REMARK 3 T11: 0.0330 T22: -0.1764 REMARK 3 T33: -0.1137 T12: 0.0515 REMARK 3 T13: 0.1824 T23: -0.0157 REMARK 3 L TENSOR REMARK 3 L11: 0.9972 L22: 2.2304 REMARK 3 L33: 1.7767 L12: 1.0000 REMARK 3 L13: -0.1956 L23: 0.1745 REMARK 3 S TENSOR REMARK 3 S11: -0.0051 S12: -0.2426 S13: 0.1106 REMARK 3 S21: 0.5764 S22: -0.0379 S23: 0.5369 REMARK 3 S31: 0.1501 S32: 0.0231 S33: 0.0429 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4P90 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-APR-14. REMARK 100 THE DEPOSITION ID IS D_1000200953. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-SEP-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22335 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.490 REMARK 200 RESOLUTION RANGE LOW (A) : 83.360 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.63 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.56900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 1YHV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.64 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM SULPHATE, 16% PEG 3350, REMARK 280 0.1M HEPES (PH 7.6), VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.68000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 249 REMARK 465 ASP A 289 REMARK 465 VAL A 290 REMARK 465 ALA A 291 REMARK 465 THR A 292 REMARK 465 GLY A 293 REMARK 465 GLN A 294 REMARK 465 ASN A 302 REMARK 465 LEU A 303 REMARK 465 GLN A 304 REMARK 465 GLN A 305 REMARK 465 GLN A 306 REMARK 465 PRO A 307 REMARK 465 LYS A 308 REMARK 465 VAL A 336 REMARK 465 GLY A 337 REMARK 465 ASP A 338 REMARK 465 THR A 415 REMARK 465 PRO A 416 REMARK 465 GLU A 417 REMARK 465 GLN A 418 REMARK 465 SER A 419 REMARK 465 ASN A 543 REMARK 465 ASN A 544 REMARK 465 HIS A 545 REMARK 465 SER B 249 REMARK 465 ASP B 250 REMARK 465 GLU B 251 REMARK 465 GLU B 252 REMARK 465 ILE B 253 REMARK 465 LEU B 254 REMARK 465 GLU B 255 REMARK 465 LYS B 256 REMARK 465 GLN B 278 REMARK 465 GLY B 279 REMARK 465 ALA B 280 REMARK 465 SER B 281 REMARK 465 GLN B 304 REMARK 465 GLN B 305 REMARK 465 GLN B 306 REMARK 465 PRO B 307 REMARK 465 LYS B 308 REMARK 465 LYS B 309 REMARK 465 GLU B 310 REMARK 465 LEU B 311 REMARK 465 ILE B 312 REMARK 465 PHE B 408 REMARK 465 GLY B 409 REMARK 465 PHE B 410 REMARK 465 CYS B 411 REMARK 465 ALA B 412 REMARK 465 GLN B 413 REMARK 465 ILE B 414 REMARK 465 THR B 415 REMARK 465 PRO B 416 REMARK 465 GLU B 417 REMARK 465 GLN B 418 REMARK 465 ASN B 543 REMARK 465 ASN B 544 REMARK 465 HIS B 545 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 251 -35.02 -33.21 REMARK 500 LEU A 331 -65.27 -100.55 REMARK 500 ASN A 389 40.54 -142.48 REMARK 500 ASP A 407 82.52 58.14 REMARK 500 ARG B 388 -17.12 77.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 2K0 A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 2K0 B 601 DBREF 4P90 A 249 545 UNP Q13153 PAK1_HUMAN 249 545 DBREF 4P90 B 249 545 UNP Q13153 PAK1_HUMAN 249 545 SEQADV 4P90 ASN A 389 UNP Q13153 ASP 389 ENGINEERED MUTATION SEQADV 4P90 GLU A 423 UNP Q13153 THR 423 ENGINEERED MUTATION SEQADV 4P90 ASP A 503 UNP Q13153 GLU 503 ENGINEERED MUTATION SEQADV 4P90 ASN B 389 UNP Q13153 ASP 389 ENGINEERED MUTATION SEQADV 4P90 GLU B 423 UNP Q13153 THR 423 ENGINEERED MUTATION SEQADV 4P90 ASP B 503 UNP Q13153 GLU 503 ENGINEERED MUTATION SEQRES 1 A 297 SER ASP GLU GLU ILE LEU GLU LYS LEU ARG SER ILE VAL SEQRES 2 A 297 SER VAL GLY ASP PRO LYS LYS LYS TYR THR ARG PHE GLU SEQRES 3 A 297 LYS ILE GLY GLN GLY ALA SER GLY THR VAL TYR THR ALA SEQRES 4 A 297 MET ASP VAL ALA THR GLY GLN GLU VAL ALA ILE LYS GLN SEQRES 5 A 297 MET ASN LEU GLN GLN GLN PRO LYS LYS GLU LEU ILE ILE SEQRES 6 A 297 ASN GLU ILE LEU VAL MET ARG GLU ASN LYS ASN PRO ASN SEQRES 7 A 297 ILE VAL ASN TYR LEU ASP SER TYR LEU VAL GLY ASP GLU SEQRES 8 A 297 LEU TRP VAL VAL MET GLU TYR LEU ALA GLY GLY SER LEU SEQRES 9 A 297 THR ASP VAL VAL THR GLU THR CYS MET ASP GLU GLY GLN SEQRES 10 A 297 ILE ALA ALA VAL CYS ARG GLU CYS LEU GLN ALA LEU GLU SEQRES 11 A 297 PHE LEU HIS SER ASN GLN VAL ILE HIS ARG ASN ILE LYS SEQRES 12 A 297 SER ASP ASN ILE LEU LEU GLY MET ASP GLY SER VAL LYS SEQRES 13 A 297 LEU THR ASP PHE GLY PHE CYS ALA GLN ILE THR PRO GLU SEQRES 14 A 297 GLN SER LYS ARG SER GLU MET VAL GLY THR PRO TYR TRP SEQRES 15 A 297 MET ALA PRO GLU VAL VAL THR ARG LYS ALA TYR GLY PRO SEQRES 16 A 297 LYS VAL ASP ILE TRP SER LEU GLY ILE MET ALA ILE GLU SEQRES 17 A 297 MET ILE GLU GLY GLU PRO PRO TYR LEU ASN GLU ASN PRO SEQRES 18 A 297 LEU ARG ALA LEU TYR LEU ILE ALA THR ASN GLY THR PRO SEQRES 19 A 297 GLU LEU GLN ASN PRO GLU LYS LEU SER ALA ILE PHE ARG SEQRES 20 A 297 ASP PHE LEU ASN ARG CYS LEU ASP MET ASP VAL GLU LYS SEQRES 21 A 297 ARG GLY SER ALA LYS GLU LEU LEU GLN HIS GLN PHE LEU SEQRES 22 A 297 LYS ILE ALA LYS PRO LEU SER SER LEU THR PRO LEU ILE SEQRES 23 A 297 ALA ALA ALA LYS GLU ALA THR LYS ASN ASN HIS SEQRES 1 B 297 SER ASP GLU GLU ILE LEU GLU LYS LEU ARG SER ILE VAL SEQRES 2 B 297 SER VAL GLY ASP PRO LYS LYS LYS TYR THR ARG PHE GLU SEQRES 3 B 297 LYS ILE GLY GLN GLY ALA SER GLY THR VAL TYR THR ALA SEQRES 4 B 297 MET ASP VAL ALA THR GLY GLN GLU VAL ALA ILE LYS GLN SEQRES 5 B 297 MET ASN LEU GLN GLN GLN PRO LYS LYS GLU LEU ILE ILE SEQRES 6 B 297 ASN GLU ILE LEU VAL MET ARG GLU ASN LYS ASN PRO ASN SEQRES 7 B 297 ILE VAL ASN TYR LEU ASP SER TYR LEU VAL GLY ASP GLU SEQRES 8 B 297 LEU TRP VAL VAL MET GLU TYR LEU ALA GLY GLY SER LEU SEQRES 9 B 297 THR ASP VAL VAL THR GLU THR CYS MET ASP GLU GLY GLN SEQRES 10 B 297 ILE ALA ALA VAL CYS ARG GLU CYS LEU GLN ALA LEU GLU SEQRES 11 B 297 PHE LEU HIS SER ASN GLN VAL ILE HIS ARG ASN ILE LYS SEQRES 12 B 297 SER ASP ASN ILE LEU LEU GLY MET ASP GLY SER VAL LYS SEQRES 13 B 297 LEU THR ASP PHE GLY PHE CYS ALA GLN ILE THR PRO GLU SEQRES 14 B 297 GLN SER LYS ARG SER GLU MET VAL GLY THR PRO TYR TRP SEQRES 15 B 297 MET ALA PRO GLU VAL VAL THR ARG LYS ALA TYR GLY PRO SEQRES 16 B 297 LYS VAL ASP ILE TRP SER LEU GLY ILE MET ALA ILE GLU SEQRES 17 B 297 MET ILE GLU GLY GLU PRO PRO TYR LEU ASN GLU ASN PRO SEQRES 18 B 297 LEU ARG ALA LEU TYR LEU ILE ALA THR ASN GLY THR PRO SEQRES 19 B 297 GLU LEU GLN ASN PRO GLU LYS LEU SER ALA ILE PHE ARG SEQRES 20 B 297 ASP PHE LEU ASN ARG CYS LEU ASP MET ASP VAL GLU LYS SEQRES 21 B 297 ARG GLY SER ALA LYS GLU LEU LEU GLN HIS GLN PHE LEU SEQRES 22 B 297 LYS ILE ALA LYS PRO LEU SER SER LEU THR PRO LEU ILE SEQRES 23 B 297 ALA ALA ALA LYS GLU ALA THR LYS ASN ASN HIS HET 2K0 A 601 31 HET 2K0 B 601 31 HETNAM 2K0 [2-CHLORO-5-(HYDROXYMETHYL)PHENYL]{5-[1-(PIPERIDIN-4- HETNAM 2 2K0 YL)-1H-PYRAZOL-4-YL]-1H-PYRROLO[2,3-B]PYRIDIN-3- HETNAM 3 2K0 YL}METHANONE FORMUL 3 2K0 2(C23 H22 CL N5 O2) FORMUL 5 HOH *43(H2 O) HELIX 1 AA1 ASP A 250 VAL A 261 1 12 HELIX 2 AA2 ASP A 265 TYR A 270 1 6 HELIX 3 AA3 GLU A 310 ASN A 322 1 13 HELIX 4 AA4 SER A 351 THR A 359 1 9 HELIX 5 AA5 ASP A 362 ASN A 383 1 22 HELIX 6 AA6 LYS A 391 ASP A 393 5 3 HELIX 7 AA7 THR A 427 MET A 431 5 5 HELIX 8 AA8 ALA A 432 THR A 437 1 6 HELIX 9 AA9 LYS A 444 GLY A 460 1 17 HELIX 10 AB1 ASN A 468 GLY A 480 1 13 HELIX 11 AB2 ASN A 486 LEU A 490 5 5 HELIX 12 AB3 SER A 491 LEU A 502 1 12 HELIX 13 AB4 SER A 511 LEU A 516 1 6 HELIX 14 AB5 GLN A 517 ALA A 524 5 8 HELIX 15 AB6 PRO A 526 SER A 529 5 4 HELIX 16 AB7 LEU A 530 THR A 541 1 12 HELIX 17 AB8 ASP B 265 LYS B 269 1 5 HELIX 18 AB9 ASN B 314 ASN B 322 1 9 HELIX 19 AC1 SER B 351 THR B 359 1 9 HELIX 20 AC2 ASP B 362 ASN B 383 1 22 HELIX 21 AC3 LYS B 391 ASP B 393 5 3 HELIX 22 AC4 ALA B 432 THR B 437 1 6 HELIX 23 AC5 LYS B 444 GLY B 460 1 17 HELIX 24 AC6 ASN B 468 GLY B 480 1 13 HELIX 25 AC7 ASN B 486 LEU B 490 5 5 HELIX 26 AC8 SER B 491 LEU B 502 1 12 HELIX 27 AC9 SER B 511 LEU B 516 1 6 HELIX 28 AD1 GLN B 517 ALA B 524 5 8 HELIX 29 AD2 PRO B 526 SER B 529 5 4 HELIX 30 AD3 LEU B 530 THR B 541 1 12 SHEET 1 AA1 5 GLU A 274 GLN A 278 0 SHEET 2 AA1 5 THR A 283 ALA A 287 -1 O VAL A 284 N ILE A 276 SHEET 3 AA1 5 VAL A 296 MET A 301 -1 O GLN A 300 N THR A 283 SHEET 4 AA1 5 LEU A 340 GLU A 345 -1 O MET A 344 N ALA A 297 SHEET 5 AA1 5 TYR A 330 TYR A 334 -1 N ASP A 332 O VAL A 343 SHEET 1 AA2 2 VAL A 385 ILE A 386 0 SHEET 2 AA2 2 ALA A 412 GLN A 413 -1 O ALA A 412 N ILE A 386 SHEET 1 AA3 2 ILE A 395 LEU A 397 0 SHEET 2 AA3 2 VAL A 403 LEU A 405 -1 O LYS A 404 N LEU A 396 SHEET 1 AA4 5 TYR B 270 LYS B 275 0 SHEET 2 AA4 5 THR B 283 ASP B 289 -1 O THR B 286 N GLU B 274 SHEET 3 AA4 5 GLU B 295 ASN B 302 -1 O GLN B 300 N THR B 283 SHEET 4 AA4 5 GLU B 339 GLU B 345 -1 O MET B 344 N ALA B 297 SHEET 5 AA4 5 TYR B 330 VAL B 336 -1 N ASP B 332 O VAL B 343 SHEET 1 AA5 2 ILE B 395 LEU B 397 0 SHEET 2 AA5 2 VAL B 403 LEU B 405 -1 O LYS B 404 N LEU B 396 SSBOND 1 CYS A 360 CYS B 360 1555 2645 2.06 SITE 1 AC1 12 ILE A 276 VAL A 284 ALA A 297 LYS A 299 SITE 2 AC1 12 GLU A 315 MET A 344 GLU A 345 TYR A 346 SITE 3 AC1 12 LEU A 347 LEU A 396 THR A 406 ASP A 407 SITE 1 AC2 10 ALA B 297 LYS B 299 VAL B 328 MET B 344 SITE 2 AC2 10 GLU B 345 TYR B 346 LEU B 347 GLY B 350 SITE 3 AC2 10 LEU B 396 ASP B 407 CRYST1 62.400 83.360 66.020 90.00 105.04 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016026 0.000000 0.004306 0.00000 SCALE2 0.000000 0.011996 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015684 0.00000